Maravai Lifesciences Holdings, Inc. Class A MRVI 深 滬
已收盤 02-06 16:00:00 美东时间
3.14
+0.050
+1.62%
華盛通- 最 高3.21
- 今 開3.17
- 成交量 112.72万股
- 最 低 3.07
- 昨 收 3.09
- 總市值 8.03亿
- 52周最高 4.40
- 市盈率 靜 --
- 換手率 0.44%
- 52周最低 1.665
- 委 比 96.49%
- 總股本 2.56亿
- 歷史最高 63.55
- 量 比 0.92
- 振 幅 4.53%
- 歷史最低 1.665
- 每 手 1
- 風險率 0.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $4.5
Wells Fargo analyst Brandon Couillard maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $4 to $4.5.
2025-12-16 02:25
Maravai LifeSciences Holdings shares are trading lower after the company reported worse-than-expected Q3 sales results.
Maravai LifeSciences Holdings shares are trading lower after the company report...
2025-11-07 05:58
Maravai LifeSciences Q3 Adj. EPS $(0.08), Inline, Sales $41.630M Miss $49.003M Estimate
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 700 percent decrease over losses of $(0.01) per share from the same period last year.
2025-11-07 05:04
Avantor® Appoints Gregory T. Lucier to its Board of Directors
Brings more than three decades of leadership experience in the life sciences industry RADNOR, Pa., Oct. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of missi...
2025-10-03 20:05
Goldman's 48 potential M&A candidates
Deal activity will rise by 15% in 2026, according to Goldman Sachs. Strategist David Kostin says M&A activity will increase next year "alongside accelerating US economic growth, improving CEO confiden...
2025-09-29 03:14
美股牛股 | 多只绩优股狂飙！Rumbleon涨超60%，Tonix制药控股涨超32%
多只绩优股狂飙！Rumbleon涨超60%，Tonix制药控股涨超32%；美国7月机票价格创3年多来最大月度涨幅！美国航空股Frontier Group涨近30%>>
2025-08-13 15:56
Maravai生命科学宣布削减成本计划
Maravai生命科学公司（Maravai LifeSciences，MRVI）周二宣布了一项年度化5000万美元的成本削减计划，目标是到2026年实现E...
2025-08-12 22:57
RBC Capital Maintains Outperform on Maravai LifeSciences, Lowers Price Target to $5
RBC Capital analyst Conor McNamara maintains Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and lowers the price target from $7 to $5.
2025-08-12 22:06
Maravai LifeSciences Holdings shares are trading higher. The company reported Q2 financial results.
Maravai LifeSciences Holdings shares are trading higher. The company reported Q...
2025-08-12 04:32
